Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study)
Titel:
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study)
Auteur:
Pinto, C. Di Fabio, F. Maiello, E. Pini, S. Latiano, T. Aschele, C. Garufi, C. Bochicchio, A. Rosati, G. Aprile, G. Giaquinta, S. Torri, V. Bardelli, A. Gion, M. Martoni, A.